Eli Lilly Aktie

769,30 EUR -21,20 EUR -2,68 %

08:09:19

FSE

810,64 USD -0,57 USD -0,07 %

nachbörslich01.02.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.752,66 Mrd. EUR

KGV100,48Div. Rendite0,78%

WKN858560

ISINUS5324571083

SymbolLLY

Eli Lilly Aktien News

Sortieren:Datum Meistgelesen

08.07.24PR NewswireLilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease

08.07.24EN, Eli LillyLilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease

04.07.24BenzingaHere's How Much $100 Invested In Eli Lilly and Co 15 Years Ago Would Be Worth Today

02.07.24PR NewswireLilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease

02.07.24EN, Eli LillyLilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease

28.06.24BenzingaInsights Into Eli Lilly and Co's Performance Versus Peers In Pharmaceuticals Sector

25.06.24EN, Eli LillyLilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria

25.06.24PR NewswireLilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria

25.06.24BenzingaThis Is What Whales Are Betting On Eli Lilly and Co

24.06.24EN, Eli LillyLilly Declares Third-Quarter 2024 Dividend

24.06.24PR NewswireLilly Declares Third-Quarter 2024 Dividend

24.06.24ZacksInvestors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know

21.06.24PR NewswireLilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolution

21.06.24EN, Eli LillyLilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolution

20.06.24EN, Eli LillyLilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products

20.06.24EN, Eli LillyAn Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®

18.06.24Benzinga(LLY) - Analyzing Eli Lilly and Co's Short Interest

18.06.24BenzingaHere's How Much $1000 Invested In Eli Lilly and Co 10 Years Ago Would Be Worth Today

17.06.24BenzingaSpotlight on Eli Lilly and Co: Analyzing the Surge in Options Activity

14.06.24BenzingaAnalyzing Eli Lilly and Co In Comparison To Competitors In Pharmaceuticals Industry

12.06.24BenzingaEli Lilly and Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)

10.06.24BenzingaUnpacking the Latest Options Trading Trends in Eli Lilly and Co

10.06.24ZacksEli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

08.06.24PR NewswireLilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks

08.06.24EN, Eli LillyLilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks

05.06.24PR NewswireLilly announces departure of Anat Ashkenazi, chief financial officer

05.06.24EN, Eli LillyLilly announces departure of Anat Ashkenazi, chief financial officer

04.06.24EN, Eli LillyMelissa Seymour to join Lilly as executive vice president of Global Quality

04.06.24PR NewswireMelissa Seymour to join Lilly as executive vice president of Global Quality

03.06.24BenzingaEli Lilly and Co's Options: A Look at What the Big Money is Thinking

01.06.24MotleyFoolThis Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors

01.06.24EN, Eli LillyUpdated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting

01.06.24PR NewswireUpdated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting

31.05.24BenzingaPerformance Comparison: Eli Lilly and Co And Competitors In Pharmaceuticals Industry

30.05.24BenzingaUrban Outfitters, Eli Lilly And 2 Other Stocks Insiders Are Selling

29.05.24EN, Eli LillyLilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases

28.05.24EN, Eli LillyLilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

28.05.24PR NewswireLilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

28.05.24ZacksEli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

24.05.24EN, Eli LillyLilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines

Eli Lilly News

Eli Lilly News: auf dieser Seite finden Sie alle Eli Lilly News und Nachrichten zur Eli Lilly Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Eli Lilly News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Eli Lilly News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.